Literature DB >> 27692175

Roles and Regulation of Epithelial Splicing Regulatory Proteins 1 and 2 in Epithelial-Mesenchymal Transition.

E-L Göttgens1, P N Span1, M M Zegers2.   

Abstract

The transformation of polarized epithelial cells into cells with mesenchymal characteristics by the morphogenetic process of epithelial-mesenchymal transition (EMT) is a well-characterized process essential for embryonic development and associated with cancer progression. EMT is a program driven by changes in gene expression induced by several EMT-specific transcription factors, which inhibit the expression of cell-cell adhesion proteins and other epithelial markers, causing a characteristic loss of cell-cell adhesion, a switch to mesenchymal cell morphology, and increased migratory capabilities. Recently, it has become apparent that in addition to these transcriptionally regulated changes, EMT may also be regulated posttranscriptionally, that is, by alternative splicing. Specifically, the epithelial splicing regulatory proteins 1 and 2 (ESRP1 and ESRP2) have been described as epithelial-specific splicing master regulators specifically involved in EMT-associated alternative splicing. Here, we discuss the regulation of ESRP activity, as well as the evidence supporting a causal role of ESRPs in EMT.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ESRP1; ESRP2; alternative splicing; carcinogenesis; cell signaling; epithelial–mesenchymal transition

Mesh:

Substances:

Year:  2016        PMID: 27692175     DOI: 10.1016/bs.ircmb.2016.06.003

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  10 in total

Review 1.  Role of CD44 isoforms in epithelial-mesenchymal plasticity and metastasis.

Authors:  Mark Primeaux; Saiprasad Gowrikumar; Punita Dhawan
Journal:  Clin Exp Metastasis       Date:  2022-01-12       Impact factor: 5.150

Review 2.  Underlying mechanisms of epithelial splicing regulatory proteins in cancer progression.

Authors:  Ying Liu; Yiwen Li; Chengcheng Du; Shouxiang Kuang; Xuehao Zhou; Jinyu Zhang; Xiang Ao
Journal:  J Mol Med (Berl)       Date:  2022-09-27       Impact factor: 5.606

3.  Genome-wide screen for differentially methylated long noncoding RNAs identifies Esrp2 and lncRNA Esrp2-as regulated by enhancer DNA methylation with prognostic relevance for human breast cancer.

Authors:  K Heilmann; R Toth; C Bossmann; K Klimo; C Plass; C Gerhauser
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

4.  Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression.

Authors:  Matjaz Rokavec; Markus Kaller; David Horst; Heiko Hermeking
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

5.  P120 Catenin Isoforms Differentially Associate with Breast Cancer Invasion and Metastasis.

Authors:  Jan-Hendrik Venhuizen; Paul N Span; Koen van den Dries; Sebastian Sommer; Peter Friedl; Mirjam M Zegers
Journal:  Cancers (Basel)       Date:  2019-09-29       Impact factor: 6.639

6.  Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer.

Authors:  Morton Freytag; Martina Kluth; Elena Bady; Claudia Hube-Magg; Georgia Makrypidi-Fraune; Hans Heinzer; Doris Höflmayer; Sören Weidemann; Ria Uhlig; Hartwig Huland; Markus Graefen; Christian Bernreuther; Corinna Wittmer; Maria Christina Tsourlakis; Sarah Minner; David Dum; Andrea Hinsch; Andreas M Luebke; Ronald Simon; Guido Sauter; Thorsten Schlomm; Katharina Möller
Journal:  BMC Cancer       Date:  2020-12-18       Impact factor: 4.430

7.  Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma.

Authors:  Asmerom T Sengal; Deborah Smith; Cameron E Snell; Samuel Leung; Aline Talhouk; Elizabeth D Williams; Jessica N McAlpine; Pamela M Pollock
Journal:  J Pathol Clin Res       Date:  2022-07-22

8.  Differential expression of p120-catenin 1 and 3 isoforms in epithelial tissues.

Authors:  Jan-Hendrik Venhuizen; Sebastian Sommer; Paul N Span; Peter Friedl; Mirjam M Zegers
Journal:  Sci Rep       Date:  2019-01-14       Impact factor: 4.379

9.  Epithelial Splicing Regulatory Protein (ESPR1) Expression in an Unfavorable Prognostic Factor in Prostate Cancer Patients.

Authors:  Hyung Ho Lee; Andy Jinseok Lee; Weon Seo Park; Jongkeun Lee; Jongkeun Park; Boram Park; Jae Young Joung; Kang Hyun Lee; Dongwan Hong; Sung Han Kim
Journal:  Front Oncol       Date:  2020-10-26       Impact factor: 6.244

10.  Modelling the developmental spliceosomal craniofacial disorder Burn-McKeown syndrome using induced pluripotent stem cells.

Authors:  Katherine A Wood; Charlie F Rowlands; Huw B Thomas; Steven Woods; Julieta O'Flaherty; Sofia Douzgou; Susan J Kimber; William G Newman; Raymond T O'Keefe
Journal:  PLoS One       Date:  2020-07-31       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.